Do gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with coeliac disease?
DOIAbstract
6nonenoneDe Re, V; Simula, Mp; Notarpietro, A; Canzonieri, V; Cannizzaro, R; Toffoli,
6nonenoneDe Re, V; Simula, Mp; Notarpietro, A; Canzonieri, V; Cannizzaro, R; Toffoli,
Celiac disease (CD) is an intestinal malabsorption characterized by intolerance to cereal proteins a...
In the last few decades, the comprehension of epidemiological, pathogenic and clinical aspects of co...
Background: an unresolved question in coeliac disease is to understand how some toxic gliadin peptid...
6nonenoneDe Re, V; Simula, Mp; Notarpietro, A; Canzonieri, V; Cannizzaro, R; Toffoli,
gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with...
OBJECTIVES: The molecular and functional properties of small intestinal tissue transglutaminase are ...
Background. Tissue transglutaminase, the coeliac autoantigen, was shown to localise in the enterocyt...
8Celiac disease (CD) is an intestinal malabsorption characterized by intolerance to cereal proteins ...
BACKGROUND: An unresolved question in coeliac disease is to understand how some toxic gliadin pept...
An unresolved question in coeliac disease is to understand how some toxic gliadin peptides, in parti...
Abstract Dendritic cells (DCs) are part of the innate immune system with a key role in initiating an...
Tissue transglutaminase (tTG) seems to be the target self-antigen for endomysial antiodies in coelia...
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into...
transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype- imp...
Abstract Background: An unresolved question in Coeliac disease (CD) is to understand how some toxic ...
Celiac disease (CD) is an intestinal malabsorption characterized by intolerance to cereal proteins a...
In the last few decades, the comprehension of epidemiological, pathogenic and clinical aspects of co...
Background: an unresolved question in coeliac disease is to understand how some toxic gliadin peptid...
6nonenoneDe Re, V; Simula, Mp; Notarpietro, A; Canzonieri, V; Cannizzaro, R; Toffoli,
gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with...
OBJECTIVES: The molecular and functional properties of small intestinal tissue transglutaminase are ...
Background. Tissue transglutaminase, the coeliac autoantigen, was shown to localise in the enterocyt...
8Celiac disease (CD) is an intestinal malabsorption characterized by intolerance to cereal proteins ...
BACKGROUND: An unresolved question in coeliac disease is to understand how some toxic gliadin pept...
An unresolved question in coeliac disease is to understand how some toxic gliadin peptides, in parti...
Abstract Dendritic cells (DCs) are part of the innate immune system with a key role in initiating an...
Tissue transglutaminase (tTG) seems to be the target self-antigen for endomysial antiodies in coelia...
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into...
transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype- imp...
Abstract Background: An unresolved question in Coeliac disease (CD) is to understand how some toxic ...
Celiac disease (CD) is an intestinal malabsorption characterized by intolerance to cereal proteins a...
In the last few decades, the comprehension of epidemiological, pathogenic and clinical aspects of co...
Background: an unresolved question in coeliac disease is to understand how some toxic gliadin peptid...
Add to ORKG